Table 1.
Sample sociodemographic characteristics, self-reported health status and prostate cancer history (n = 190)
| Variable | |
|---|---|
| Age | 70.8 years (8.7 years) |
| Married or de facto relationship | 75 % |
| Retired | 68 % |
| Born in Australia | 66 % |
| University or college degree | 66 % |
| BMI | |
| Overweight range | 47 % |
| Obese range | 28 % |
| Smoking history | |
| Ex-smoker | 45 % |
| Current smoker | 7 % |
| Comorbid health conditions | |
| Any condition | 92 % |
| Back pain | 59 % |
| Osteoarthritis or degenerative arthritis | 54 % |
| High blood pressure | 48 % |
| Depression or anxiety | 27 % |
| Heart disease | 22 % |
| Diabetes | 18 % |
| Lung disease | 11 % |
| At least one condition limited current activities | 58 % |
| Time since prostate cancer diagnosis | 6 years (4.9 years) |
| Gleason score ≥ 8a | 71 % |
| Prostate cancer stage b | |
| T2 | 20 % |
| T3 | 55 % |
| T4 | 24 % |
| PSA levelc | 50.6 ng/mL* (106.3 ng/mL) |
| Prostate cancer treatment d | |
| Androgen deprivation therapy | 97 % |
| Radiation therapy | 69 % |
| Prostatectomy | 44 % |
| Chemotherapy | 31 % |
| Active surveillance | 4 % |
| Watchful waiting | 4 % |
| Orchidectomy | 2 % |
Values in parentheses are standard deviations for continuous variables
* PSA range = 0.01–588.9 ng/mL; PSA median = 7.94 ng/mL
a n = 114; b n = 83; c n = 160; d n = 171